ANTXNASDAQHealthcare

AN2 THERAPEUTICS INC

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$4.00

+1.14%

Alpha Vantage · 11/6/2026

Industry: BiotechnologyCategory: Domestic Common StockCurrency: USDNews: 1 recent

Analyze ANTX free

One-year price history

Adjusted daily closes · 252 observations · as of Nov 6, 2026

Historical data, not a forecast

1 month

-14.5%

3 months

-32.3%

6 months

-10.3%

1 year

+257.1%

Year to date

+250.9%

52-week range

$1.03 – $6.28

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$150.9M

P/E

-4.2

P/B

P/S

—

Revenue

Net income

-$36.28M

Diluted EPS

-1.06

Gross margin

—

Net margin

—

Return on equity

-53.50%

Total debt

Cash

$44.32M

Free cash flow

-$30.68M

Latest eight reported quarters

Reported quarterly values, newest first

Period	Revenue	Net income	Gross margin	Net margin	Free cash flow
Jun 30, 2026	$0	-$8.19M	—	—	-$7M
Mar 31, 2026	$0	-$10.03M	—	—	-$12.07M
Dec 31, 2025	$0	-$8.71M	—	—	-$5.24M
Sep 30, 2025	$0	-$9.35M	—	—	-$6.38M
Jun 30, 2025	$0	-$6.46M	—	—	-$7.6M
Mar 31, 2025	$0	-$10.65M	—	—	-$10.62M
Dec 31, 2024	$0	-$7.52M	—	—	-$5.27M
Sep 30, 2024	$0	-$12.75M	—	—	-$12.01M

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent ANTX news

All market news

BioSpace·Nov 5, 202654 signal

AN2 Therapeutics to Present at 2026 Jefferies Global Healthcare Conference in London

AN2 Therapeutics, Inc. (NASDAQ: ANTX) announced that its Co-Founder, Chairman, President, and CEO, Eric Easom, will present at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 9:30 am GMT. The company, a clinical stage biopharmaceutical firm, will also have management available for one-on-one meetings. A webcast of the presentation will be accessible on the Investors section of the AN2 Therapeutics website.

Original source